Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain

We report in vivo proton magnetic resonance (MR) spectroscopic findings in three benign infective/inflammatory lesions (one case each of tuberculoma, fungal granuloma, and xanthogranuloma), which showed high choline along with the presence of lipid/lactate, a feature characteristically described in neoplastic lesions. Histopathology of the lesions showed inflammatory cellular infiltrates with areas of necrosis/caseation. The spectroscopic‐visible increased choline resonance in these lesions is probably the result of cellularity. We conclude that increased choline, along with the presence of lipid/lactate is a nonspecific finding and may not be of much value in the differentiation of neoplastic from nonneoplastic infective/inflammatory intracranial mass lesions. J. Magn. Reson. Imaging 2001;14:8–15. © 2001 Wiley‐Liss, Inc.

[1]  Paul A. Bottomley,et al.  4480228 Selective volume method for performing localized NMR spectroscopy , 1985 .

[2]  H. Poptani,et al.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.

[3]  J. Hennig,et al.  HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.

[4]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[5]  G. Fein,et al.  Deep gray matter structures in HIV infection: a proton MR spectroscopic study. , 1996, AJNR. American journal of neuroradiology.

[6]  M. Oudkerk,et al.  Hydrogen Magnetic Resonance Spectroscopy Follow-up After Radiation Therapy of Human Brain Cancer: Unexpected Inverse Correlation Between the Changes in Tumor Choline Level and Post-Gadolinium Magnetic Resonance Imaging Contrast , 1995, Investigative radiology.

[7]  I. Wilkinson,et al.  Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. , 1995, Radiology.

[8]  G J Barker,et al.  The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio , 1993, Magnetic resonance in medicine.

[9]  B D Ross,et al.  Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols , 1991, NMR in biomedicine.

[10]  B. Ross,et al.  Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. , 1999, AJR. American journal of roentgenology.

[11]  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997 .

[12]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[13]  H. Poptani,et al.  Finger printing of mycobacterium tuberculosis in patients with intracranial tuberculomas by using in vivo, ex vivo, and in vitro magnetic resonance spectroscopy , 1996, Magnetic resonance in medicine.

[14]  V. Haughton,et al.  Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. , 1997, AJNR. American journal of neuroradiology.

[15]  O. Pryds,et al.  Metabolite concentrations in the developing brain estimated with proton MR spectroscopy , 1994, Journal of magnetic resonance imaging : JMRI.

[16]  S. Hunter,et al.  Solitary intracerebral juvenile xanthogranuloma. Case report and review of the literature. , 1997, Pediatric neurosurgery.

[17]  M. Aguilar,et al.  Localized hypothalamic histiocytosis X. Report of a case. , 1969, Archives of neurology.

[18]  A. Stillman,et al.  Proton MR spectroscopy and neuropsychological testing in adrenoleukodystrophy. , 1997, AJNR. American journal of neuroradiology.

[19]  L. Chang,et al.  Metabolite abnormalities in progressive rnultifocal leukoencephalopathy by proton magnetic resonance spectroscopy , 1997, Neurology.

[20]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[21]  R. Gupta,et al.  Intracranial tuberculomas: MRI signal intensity correlation with histopathology and localised proton spectroscopy. , 1993, Magnetic resonance imaging.

[22]  J. Ruíz-Cabello,et al.  Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.

[23]  V. Haughton,et al.  Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. , 1998, AJNR. American journal of neuroradiology.

[24]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[25]  G. Fein,et al.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients , 1999, Neurology.

[26]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.